Jounce Therapeutics, Inc. Operating Margin 2017-2022 | JNCE
Current and historical operating margin for Jounce Therapeutics, Inc. (JNCE) over the last 10 years. The current operating profit margin for Jounce Therapeutics, Inc. as of December 31, 2022 is %.
| Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2021-12-31 | $0.03B | $-0.09B | -337.04% |
| 2019-12-31 | $0.15B | $0.05B | 36.05% |
| 2019-09-30 | $0.17B | $0.07B | 44.31% |
| 2019-06-30 | $0.06B | $-0.03B | -52.38% |
| 2019-03-31 | $0.07B | $-0.03B | -47.69% |
| 2018-12-31 | $0.07B | $-0.03B | -49.23% |
| 2018-09-30 | $0.06B | $-0.04B | -70.69% |
| 2018-06-30 | $0.06B | $-0.04B | -59.02% |
| 2018-03-31 | $0.06B | $-0.03B | -53.23% |
| 2017-12-31 | $0.07B | $-0.02B | -26.76% |
| 2017-09-30 | $0.08B | $-0.00B | -2.56% |
| 2017-06-30 | $0.08B | $0.01B | 7.79% |
